Cantor Fitzgerald Weighs in on TSHA FY2026 Earnings
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Taysha Gene Therapies in a report released on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska expects that the company will post earnings per share of ($0.42) for the year. Cantor Fitzgerald currently has a […]
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Taysha Gene Therapies in a report released on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska expects that the company will post earnings per share of ($0.42) for the year. Cantor Fitzgerald currently has a […]
